Ameer MA, Chaudhry H, Mushtaq J, Khan OS, Babar M, Hashim T, et al. An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management. Cureus. 2022;14(10).
Chan OT, Madaio MR, Shlomchik MJ, Chan OI, Madaio MP. The central and multiple roles of B cells in lupus pathogenesis. Immunol Rev. 1999;169(1):107–21.
Article CAS PubMed Google Scholar
Mok C, Lau C. Pathogenesis of systemic lupus erythematosus. J Clin Pathol. 2003;56(7):481–90.
Article CAS PubMed PubMed Central Google Scholar
Moulton VR, Suarez-Fueyo A, Meidan E, Li H, Mizui M, Tsokos GC. Pathogenesis of human systemic lupus erythematosus: a cellular perspective. Trends Mol Med. 2017;23(7):615–35.
Article CAS PubMed PubMed Central Google Scholar
Pan L, Lu M-P, Wang J-H, Xu M, Yang S-R. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2020;16:19–30.
Morand EF, Vital EM, Petri M, van Vollenhoven R, Wallace DJ, Mosca M, et al. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I). Lancet. 2023;401(10381):1001–10.
Article CAS PubMed Google Scholar
Parra Sánchez AR, Voskuyl AE, van Vollenhoven RF. Treat-to-target in systemic lupus erythematosus: advancing towards its implementation. Nat Rev Rheumatol. 2022;18(3):146–57.
De Groof A, Hémon P, Mignen O, Pers J-O, Wakeland EK, Renaudineau Y, et al. Dysregulated lymphoid cell populations in mouse models of systemic lupus erythematosus. Clin Rev Allergy Immunol. 2017;53(2):181–97.
Ali M. Studies on bee venom and its medical uses. Int J Adv Res Technol. 2012;1(2):69–83.
Elieh Ali Komi D, Shafaghat F, Zwiener RD. Immunology of bee venom. Clin Rev Allergy Immunol. 2018;54:386–96.
Article CAS PubMed Google Scholar
Oršolić N. Bee venom in cancer therapy. Cancer Metastasis Rev. 2012;31:173–94.
Wehbe R, Frangieh J, Rima M, El Obeid D, Sabatier J-M, Fajloun Z. Bee venom: Overview of main compounds and bioactivities for therapeutic interests. Molecules. 2019;24(16):2997.
Article CAS PubMed PubMed Central Google Scholar
Jo M, Park MH, Kollipara PS, An BJ, Song HS, Han SB, et al. Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway. Toxicol Appl Pharmcol. 2012;258(1):72–81.
Liu C-c, Hao D-j, Zhang Q, An J, Zhao J-j, Chen B, et al. Application of bee venom and its main constituent melittin for cancer treatment. Cancer Chemother Pharmacol. 2016;78:1113–30.
Article CAS PubMed Google Scholar
Rady I, Siddiqui IA, Rady M, Mukhtar H. Melittin, a major peptide component of bee venom, and its conjugates in cancer therapy. Cancer Lett. 2017;402:16–31.
Article CAS PubMed PubMed Central Google Scholar
Lee G, Bae H. Anti-inflammatory applications of melittin, a major component of bee venom: Detailed mechanism of action and adverse effects. Molecules. 2016;21(5):616.
Article PubMed PubMed Central Google Scholar
Park HJ, Son DJ, Lee CW, Choi MS, Lee US, Song HS, et al. Melittin inhibits inflammatory target gene expression and mediator generation via interaction with IκB kinase. Biochem Pharmacol. 2007;73(2):237–47.
Article CAS PubMed Google Scholar
Park HJ, Lee HJ, Choi MS, Son DJ, Song HS, Song MJ, et al. JNK pathway is involved in the inhibition of inflammatory target gene expression and NF-kappaB activation by melittin. J Inflamm. 2008;5:1–13.
He S-d, Tan N, Sun C-x, Liao K-h, Zhu H-j, Luo X-g, et al. Treatment with melittin induces apoptosis and autophagy of fibroblast-like synoviocytes in patients with rheumatoid arthritis. Curr Pharm Biotechnol. 2020;21(8):734–40.
Article CAS PubMed Google Scholar
Kim S-K, Park K-Y, Yoon W-C, Park S-H, Park K-K, Yoo D-H, et al. Melittin enhances apoptosis through suppression of IL-6/sIL-6R complex-induced NF-κB and STAT3 activation and Bcl-2 expression for human fibroblast-like synoviocytes in rheumatoid arthritis. Joint Bone Spine. 2011;78(5):471–7.
Article CAS PubMed Google Scholar
Nah S-S, Ha E, Mun SH, Won H-J, Chung J-H. Effects of melittin on the production of matrix metalloproteinase-1 and-3 in rheumatoid arthritic fibroblast-like synoviocytes. J Pharmacol Sci. 2008;106(1):162–6.
Article CAS PubMed Google Scholar
Fennell JF, Shipman WH, Cole LJ. Antibacterial action of melittin, a polypeptide from bee venom. Proc Soc Exp Biol Med. 1968;127(3):707–10.
Article CAS PubMed Google Scholar
Baek H, Park S-Y, Ku SJ, Ryu K, Kim Y, Bae H, et al. Bee venom phospholipase A2 induces regulatory T cell populations by suppressing apoptotic signaling pathway. Toxins. 2020;12(3):198.
Article CAS PubMed PubMed Central Google Scholar
Choi G-M, Lee B, Hong R, Park S-Y, Cho D-E, Yeom M, et al. Bee venom phospholipase A2 alleviates collagen-induced polyarthritis by inducing Foxp3 + regulatory T cell polarization in mice. Sci Rep. 2021;11(1):3511.
Article CAS PubMed PubMed Central Google Scholar
Lee G, Kang G-H, Bae H. Bee venom phospholipase A2 suppression of experimental autoimmune encephalomyelitis is dependent on its enzymatic activity. Mol Cell Toxicol. 2019;15:307–13.
Son DJ, Lee JW, Lee YH, Song HS, Lee CK, Hong JT. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol Ther. 2007;115(2):246–70.
Article CAS PubMed Google Scholar
Stuhlmeier KM. Apis mellifera venom and melittin block neither NF-κB-p50-DNA interactions nor the activation of NF-κB, instead they activate the transcription of proinflammatory genes and the release of reactive oxygen intermediates. J Immunol. 2007;179(1):655–64.
Article CAS PubMed Google Scholar
Kwon Y-B, Kim J-H, Yoon J-H, Lee J-D, Han H-J, Mar W-C, et al. The analgesic efficacy of bee venom acupuncture for knee osteoarthritis: a comparative study with needle acupuncture. Am J Chin Med. 2001;29(02):187–99.
Article CAS PubMed Google Scholar
Choi MS, Park S, Choi T, Lee G, Haam K-K, Hong M-C, et al. Bee venom ameliorates ovalbumin induced allergic asthma via modulating CD4 + CD25 + regulatory T cells in mice. Cytokine. 2013;61(1):256–65.
Article CAS PubMed Google Scholar
Eggenhuizen PJ, Ng BH, Ooi JD. Treg enhancing therapies to treat autoimmune diseases. Int J Mol Sci. 2020;21(19):7015.
Article CAS PubMed PubMed Central Google Scholar
Scheinecker C, Göschl L, Bonelli M. Treg cells in health and autoimmune diseases: new insights from single cell analysis. J Autoimmun. 2020;110:102376.
Article CAS PubMed Google Scholar
Spence A, Klementowicz JE, Bluestone JA, Tang Q. Targeting Treg signaling for the treatment of autoimmune diseases. Curr Opin Immunol. 2015;37:11–20.
Comments (0)